Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Review

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

          
Total article views   Abstract views HTML views PDF downloads Totals
10,041 Dovepress* 6,721 508+ 1,963 7,229
PubMed Central* 0 2,812 419 2,812
Totals 6,721 3,320 2,382 10,041
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar